GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
120.19
+1.93 (1.63%)
At close: Oct 6, 2025, 4:00 PM EDT
120.15
-0.04 (-0.03%)
After-hours: Oct 6, 2025, 7:21 PM EDT

Company Description

GeneDx Holdings Corp., a genomics company, provides genetic testing services.

It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services.

The company also develops an AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing.

The company is headquartered in Stamford, Connecticut.

GeneDx Holdings Corp.
GeneDx Holdings logo
CountryUnited States
Founded2017
IndustryDiagnostics & Research
SectorHealthcare
Employees1,000
CEOKatherine Stueland

Contact Details

Address:
North Tower, 6th Floor
Stamford, Connecticut 06902
United States
Phone888 729 1206
Websitegenedx.com

Stock Details

Ticker SymbolWGS
ExchangeNASDAQ
Stock TypeCommon Stock
Share ClassClass A Shares
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001818331
CUSIP Number81663L200
ISIN NumberUS81663L2007
Employer ID85-1966622
SIC Code8000

Key Executives

NamePosition
Katherine A. StuelandPresident, Chief Executive Officer and Director
Kevin Feeley CPAChief Financial Officer
Dr. Bryan M. Dechairo Ph.D.Chief Operating Officer
Heidi C. Chen J.D.Chief Legal Officer
Jami BiliboacaHead of People Strategy
Melanie DuquetteChief Growth Officer
Dr. Martin G. Reese Ph.D.President of Fabric Genomics

Latest SEC Filings

DateTypeTitle
Sep 30, 2025144Filing
Sep 30, 2025144Filing
Sep 18, 20258-KCurrent Report
Sep 10, 2025EFFECTNotice of Effectiveness
Sep 5, 2025POS AMPost-Effective amendments for registration statement
Aug 27, 2025144Filing
Aug 26, 2025SCHEDULE 13D/AFiling
Aug 22, 2025144Filing
Aug 14, 2025SCHEDULE 13G/AFiling
Aug 6, 2025SCHEDULE 13G/AFiling